Currently out of the existing stock ratings of Luca Issi, 104 are a HOLD (37.68%), 171 are a BUY (61.96%), 1 are a SELL (0.36%).

Luca Issi

Work Performance Price Targets & Ratings Chart

Analyst Luca Issi, currently employed at RBC, carries an average stock price target met ratio of 45.93% that have a potential upside of 44.75% achieved within 142 days.

Luca Issi’s has documented 538 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ARGX, argenx NV ADR at 27-Feb-2026.

Wall Street Analyst Luca Issi

Analyst best performing recommendations are on KRRO (FREQUENCY THERAPEUTICS).
The best stock recommendation documented was for KRRO (FREQUENCY THERAPEUTICS) at 11/13/2025. The price target of $8 was fulfilled within 1 day with a profit of $23.42 (74.54%) receiving and performance score of 745.39.

Average potential price target upside

ALLO Allogene Therapeutics ALNY Alnylam Pharmaceuticals ARWR Arrowhead Pharmaceuticals BLUE Bluebird bio CRSP Crispr Therapeutics AG DRNA Dicerna Pharmaceuticals IONS Ionis Pharmaceuticals RGNX Regenxbio WVE Wave Life Sciences Ltd SGMO Sangamo Therapeutics ADVM Adverum Biotechnologies CRBU Caribou Biosciences EDIT Editas Medicine FIXX Homology Medicines NTLA Intellia Therapeutics GRPH Graphite Bio VERV Verve Therapeutics MRNA Moderna MGTX MeiraGTx Holdings PLC BEAM Beam Therapeutics  BMRN Biomarin Pharmaceutical QURE Uniqure NV FDMT 4D Molecular Therapeutics  APLS Apellis Pharmaceuticals DYN Dyne Therapeutics  RARE Ultragenyx RNA Avidity Biosciences  KRRO Frequency Therapeutics LXEO Lexeo Therapeutics, Common Stock ASND Ascendis Pharma AS ARGX argenx NV ADR FULC Fulcrum Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Jan-2026

$5

$2.22 (79.86%)

1 months 20 days ago
(09-Jan-2026)

1/10 (10%)

$3.29 (192.40%)

148

Sell Since 10-Oct-2025

4 months 19 days ago
(10-Oct-2025)

0/3 (0%)

$2.86 (55.64%)

Buy Since 08-Oct-2021

7 months 22 days ago
(07-Jul-2025)

0/4 (0%)

$15.8 (97.53%)

Buy Since 08-Aug-2024

$10

9 months 15 days ago
(14-May-2025)

0/2 (0%)

$6.92 (224.68%)

Buy Since 05-Aug-2021

9 months 15 days ago
(14-May-2025)

2/9 (22.22%)

$12.2 (210.34%)

94

Show more analysts

Please expand the browser size to see the chart

Which stock is Luca Issi is most bullish on?

Potential upside of $132.08 has been obtained for ALNY (ALNYLAM PHARMACEUTICALS)

Which stock is Luca Issi is most reserved on?

Potential downside of -$23.57 has been obtained for MRNA (MODERNA)

What Year was the first public recommendation made by Luca Issi?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?